HBE1 and hepatocellular carcinoma: Hence, the followings mitigations are paramount: first, the screening of the donated blood for HBeAb and later confirming the absence of the viral particles using PCR should be a prerequisite before transfusing the blood into recipients, and second, the monitoring of the patients with Anti-HBe antibodies for early detection and management of HCC should be a necessity.